A genomewide screen using array comparative genomic hybridization (array‐CGH) and gene expression profiling identified PVT1 as a candidate oncogene in breast and ovarian cancers, acute myeloid leukemia, and Hodgkin lymphoma 10, 11. This evidence concerns the gene PVT1 and ovarian carcinoma.